Management of Percutaneous or Permucosal Exposure to Blood or Body Fluid Letter for Follow- up Physician form, HLTH 2340 (BC Ministry of Health)

Scroll to Top

The British Columbia Centre for Excellence in HIV/AIDS Laboratory has discontinued gp-41 resistance testing as T-20 (enfuvirtide/Fuzeon) is no longer available in Canada as of March 31, 2025